CN103040849A - Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof - Google Patents

Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof Download PDF

Info

Publication number
CN103040849A
CN103040849A CN2011103077622A CN201110307762A CN103040849A CN 103040849 A CN103040849 A CN 103040849A CN 2011103077622 A CN2011103077622 A CN 2011103077622A CN 201110307762 A CN201110307762 A CN 201110307762A CN 103040849 A CN103040849 A CN 103040849A
Authority
CN
China
Prior art keywords
preparation
tannic acid
water
feature
oil phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011103077622A
Other languages
Chinese (zh)
Inventor
杨俊�
杨春广
范秉琳
邱培勇
阎玺庆
袁会峰
王清华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang Medical University
Original Assignee
Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang Medical University filed Critical Xinxiang Medical University
Priority to CN2011103077622A priority Critical patent/CN103040849A/en
Publication of CN103040849A publication Critical patent/CN103040849A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to a tannic acid preparation and a preparation method, and the tannic acid preparation is characterized by comprising, by weight, 2-30% of tannic acid, 40-75% of pharmaceutical adjuvants, and 20-50% of water. The pharmaceutical adjuvants used in the preparation comprise glycerin, monoglyceride stearate, beeswax, Vaseline, paraffin, tween, span, sodium bisulfate, ethylparaben, etc. The preparation method comprises the following steps: dissolving tannic acid by a little water or ethanol, heating to 55-85 DEG C to prepare an oil phase and a water phase, finally adding the water phase into the oil phase under uniform stirring, and performing condensation and split charging to obtain the tannic acid preparation. The preparation comprises paste agents (ointment, plaster), cream, emulsion, oil agents, water aqua, and the like, and the tannic acid content can be determined by a spectrophotometric method. The prepared tannic acid preparation conforms with medicine standards, and is suitable for the treatment of burn, bedsore and diaper dermatitis (neonatal red buttock) and the like.

Description

A kind of tannic acid preparation and preparation method for the treatment of burn, decubital ulcer and diaper dermatitis
Technical field
The present invention relates to a kind of tannic acid preparation and preparation method, meet drug standard, be mainly used in treating the diseases such as burn, decubital ulcer, diaper dermatitis, belong to biomedicine field.
Background technology
Tannic acid (Gallotannin, Tannin), have another name called tannic acid, tannin, tannin, two gallic acids, larch extract, gallotannic acid, tannin, charcoal Buddhist nun acid, gentle acid, molecular weight is 1701.20, and fusing point is 210~215 ℃, little have a special odor, the astringent taste that tool is strong reveals that to put in light and the air complexion changed dark, water-soluble, easy molten ethanol, acetone and glycerol are dissolved in ether, benzene, chloroform and petroleum ether hardly.Tannic acid energy precipitating proteins, all can form insoluble complex with alkaloid, glycoside and heavy metal etc., the Chang Zuowei astringent, the local use not only treated the diseases such as exudative ulcer, scald, decubital ulcer, hemorrhoid, eczema, stomatitis, tonsillitis, pharyngolaryngitis, and with its solution gastric lavage the poisonings such as year of Apomorphinum, scholar, Folium Digitalis Purpureae, lead, silver, copper, zinc had Detoxication.
Because tannic acid is water-disintegrable tannin; the a large amount of use is absorbed into meeting infringement liver in the body; therefore tannic acid often is made into external preparation for clinical; such as tannic acid ointment energy precipitating proteins; astriction is arranged; make the skin hardening; thereby protection mucosa; prevent undue secretion and hemostasis; and can reduce local pain, the blood plasma that reduces injury oozes out, and prevents the effect that antibacterial infects; can be used for the treatment burn; eczema; decubital ulcer and diaper dermatitis (neonate diaper dermatitis); it is uneven that but the tannic acid ointment that previous methods is made often exists tannic acid to disperse, and granule is thicker, easy oxidation discoloration; the substrate layering easily occurs in the storage process; usually smear inequality during clinical use, lowered effective contact area of tannic acid and skin, directly affect the effect of medicine.
Summary of the invention
The tannic acid preparation of the present invention's preparation belongs to weak water-in-oil type preparation, and containing by weight tannic acid is 2 ~ 30%, pharmaceutic adjuvant 40 ~ 75% and water 20 ~ 50%, outward appearance such as emulsifiable paste shape, feel is fine and smooth, meets medicinal standard, is mainly used in treating the diseases such as burn, decubital ulcer, diaper dermatitis.
The tannic acid preparation of the present invention's preparation comprises unguentum (ointment, plaster), cream, Emulsion, oil preparation, water preparation, contain principal agent tannic acid (being 2 ~ 30% by weight), a certain proportion of pharmaceutic adjuvant comprises that glyceryl monostearate, Cera Flava, vaseline, paraffin etc. are main ingredient, glycerol etc. are wetting agent, tween, span etc. are emulsifying agent and surfactant, sodium sulfitees etc. are antioxidant, and ethyl hydroxybenzoate etc. are antiseptic (being 40 ~ 45% by weight) and suitable quantity of water (water is 20 ~ 50% by weight).
Tannic acid formulation preparation method of the present invention comprises the steps:
Figure 261078DEST_PATH_IMAGE001
With a small amount of water or dissolve with ethanol tannic acid, add the glycerol mixing, obtain glycerinum acidi tannici solution;
Glyceryl monostearate, Cera Flava, vaseline, paraffin, tween etc. are heated to 55 ~ 85 ℃, and stirring obtains oil phase;
Figure 463969DEST_PATH_IMAGE003
Glycerinum acidi tannici solution, this dish, water, antiseptic etc. are heated to 55 ~ 85 ℃, and stirring obtains water;
Figure 602826DEST_PATH_IMAGE004
Being heated in 55 ~ 85 ℃ of situations, water is joined in the oil phase, the limit edged stirs, and the condensation packing gets the tannic acid preparation.
The tannic acid preparation major advantage of the present invention's preparation is to adopt ethanol or water dissolution tannic acid, adds emulsifying agent, surfactant and wetting agent, and the emulsifying degree is high, non-oxidizability is strong, good stability has guaranteed product quality so that this tannic acid preparation evenly, fine and smooth, without granular sensation.The tannic acid preparation advantage of the present invention's preparation is easy to smear evenly when being clinical use, effectively increase the contact area of tannic acid and skin, directly promote drug effect, when but this tannic acid preparation shortcoming is large-area applications, because wound surface is easy to absorb, liver there is violent toxicity, cause hepatic necrosis when serious, and the intensification wound surface, so delayed healing is unsuitable large tracts of land or life-time service.
The tannic acid preparation tannic acid qualitative reaction of the present invention preparation: get this tannic acid preparation a little, it is an amount of to add purified water, boils, lets cool, filters, and gets filtrate 1ml and adds 2 of liquor ferri trichloridis, namely aobvious black-and-blue, adds sulphuric acid again, presents yellow mercury oxide again.
The tannic acid preparation tannic acid quantitative testing of the present invention's preparation:
Figure 186254DEST_PATH_IMAGE001
It is an amount of that precision takes by weighing the tannic acid reference substance, and water is mixed with every milliliter of reference substance solution that contains 0.01mg; Precision take by weighing the present invention preparation the tannic acid preparation a little, add 70 ~ 80 ℃ of hot water and dispose suitable solution, and use a small amount of decolorizing with activated carbon, filter discard at the beginning of filtrate, get again subsequent filtrate and dispose suitable solution; Use spectrophotography, measure the solution absorption degree at the wavelength place of 276nm, calculate tannic acid content.
Linear relationship, repeatability and the response rate of tannic acid content are good in this spectrophotometry sample, are fit to the tannic acid preparation tannic acid quantitative testing of the present invention's preparation.
The tannic acid preparation preparation process of the present invention's preparation is used medicinal raw material and pharmaceutic adjuvant, produce according to the pharmaceutical production working specification, meet drug standard fully, namely meet " the Drug Administration Law of People's Republic of China ", " medicine registration management way " and " second regulation of Chinese pharmacopoeia.
With Canis familiaris L., rabbit, Cavia porcellus, rat and mice (particularly new born animal) research experiment, the tannic acid preparation of the present invention's preparation can promote skin burn, skin ulcer, soda acid to cause the incrustation healings such as scytitis, the blood plasma that reduces injury oozes out, and prevents bacterial growth.Through clinical life-time service, the disease effects such as tannic acid preparation for treating burn, eczema, decubital ulcer and diaper dermatitis (neonate diaper dermatitis) of the present invention's preparation are good.
The specific embodiment
1. tannic acid ointment is write out a prescription:
Raw material Recipe quantity
Tannic acid 50g
Glycerol 50g
Sodium sulfite 1g
Glyceryl monostearate 120g
Cera Flava 50g
Paraffin 50g
Yellow Vaselin 50g
Liquid paraffin 250g
Sorbester p17 20g
Tween 80 10g
Ethyl hydroxybenzoate 2g
Water Add to 1000g
2. tannic acid ointment preparation:
First with tannic acid with a small amount of ethanol or water dissolution, then with the glycerol mixing, get glycerinum acidi tannici solution.Glyceryl monostearate, Cera Flava, paraffin, Yellow Vaselin, liquid paraffin and sorbester p17 are heated to 70 ℃, and stirring obtains oil phase.Glycerinum acidi tannici solution, Tween 80, ethyl hydroxybenzoate and water are heated to 70 ℃, and stirring obtains water.Water is joined in the oil phase, and the limit edged stirs, and the condensation packing gets tannic acid ointment.
3. tannic acid check:
Figure 483560DEST_PATH_IMAGE001
Qualitative reaction: get the about 1g of this tannic acid preparation, add purified water 5ml, boil, let cool, filter, get filtrate 1ml and add 2 of liquor ferri trichloridis, namely aobvious black-and-blue, add again sulphuric acid, present yellow mercury oxide again.
Figure 793319DEST_PATH_IMAGE002
Quantitative testing: precision takes by weighing tannic acid reference substance 50.0mg, puts in the 100ml measuring bottle, and water is mixed with every milliliter of storing solution that contains 0.5mg; The accurate storing solution 2ml that draws puts in the 100ml measuring bottle, adds water and puts scale, shakes up, and water is mixed with every milliliter of reference substance solution that contains 0.01mg; Precision takes by weighing this tannic acid ointment 1.0g, adds 70 ℃ of hot water 20ml, after stirring makes it to dissolve, change the 100ml measuring bottle over to, add again water approximately to 80ml, put up and down constantly jolting of hot bath, make the tannic acid dissolving, and cooling solidifies substrate, place room temperature after, add water to scale, shake up, use a small amount of decolorizing with activated carbon, filter and discard just filtrate, get again subsequent filtrate and dispose suitable solution; Use spectrophotography, measure the solution absorption degree at the wavelength place of 276nm, calculate tannic acid content with reference substance.
4. this tannic acid ointment purposes:
This tannic acid ointment meets medicinal standard, is mainly used in treating the diseases such as burn, decubital ulcer, diaper dermatitis (neonate diaper dermatitis).

Claims (10)

1. tannic acid preparation, it is characterized in that containing by weight tannic acid is 2 ~ 30%, pharmaceutic adjuvant 40 ~ 75% and water 20 ~ 50%.
2. pharmaceutic adjuvant claimed in claim 1, its feature comprises glycerol, glyceryl monostearate, Cera Flava, vaseline, paraffin.
3. pharmaceutic adjuvant claimed in claim 1, its feature also comprises tween, span emulsifying agent.
4. preparation claimed in claim 1, its feature also contains sodium sulfite, ethyl hydroxybenzoate, benzoic acid antiseptic.
5. preparation claimed in claim 1, its preparation method comprises the steps:
Figure 2011103077622100001DEST_PATH_IMAGE001
With a small amount of water or dissolve with ethanol tannic acid, add the glycerol mixing, obtain glycerinum acidi tannici solution;
Figure 463589DEST_PATH_IMAGE002
Glyceryl monostearate, Cera Flava, vaseline, paraffin, tween are heated to 55 ~ 85 ℃, and stirring obtains oil phase;
Figure 2011103077622100001DEST_PATH_IMAGE003
Glycerinum acidi tannici solution, span, water, antiseptic are heated to 55 ~ 85 ℃, and stirring obtains water;
Figure 443046DEST_PATH_IMAGE004
Being heated in 55 ~ 85 ℃ of situations, water is joined in the oil phase, the limit edged stirs, and the condensation packing gets the tannic acid preparation.
6. the described preparation of claim 5, its feature comprises unguentum, cream, Emulsion, oil preparation, water preparation.
7. the described preparation of claim 6 is characterized in that unguentum comprises ointment, plaster.
8. tannic acid preparation claimed in claim 5 is characterized in that adopting spectrophotometry tannic acid content.
9. preparation claimed in claim 6, its feature meets drug standard.
10. preparation claimed in claim 9 is characterized in that being applicable to burn, decubital ulcer, diaper dermatitis treatment.
CN2011103077622A 2011-10-12 2011-10-12 Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof Pending CN103040849A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011103077622A CN103040849A (en) 2011-10-12 2011-10-12 Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011103077622A CN103040849A (en) 2011-10-12 2011-10-12 Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof

Publications (1)

Publication Number Publication Date
CN103040849A true CN103040849A (en) 2013-04-17

Family

ID=48053861

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011103077622A Pending CN103040849A (en) 2011-10-12 2011-10-12 Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103040849A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394072A (en) * 2013-06-26 2013-11-20 千足珍珠集团股份有限公司 Paste for treating nucleus of fresh-water nuclear pearl, and preparation method and application thereof
CN103585334A (en) * 2013-11-17 2014-02-19 戴世玲 Compound diaper ointment
CN104479455A (en) * 2014-12-18 2015-04-01 陈林 Marking liquid specially used for radiotherapy and marking pen applying marking liquid
WO2016008999A1 (en) * 2014-07-16 2016-01-21 Pierre Fabre Medicament Pharmaceutical and/or cosmetic compositions that are decontaminated by high pressure

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
田霞等: "新鞣酸软膏的制备工艺与质量标准研究", 《中国医药导报》 *
胡立荣等: "新鞣酸软膏的制备与临床应用 ", 《儿科药学杂志》 *
胡立荣等: "新鞣酸软膏的制备与临床应用", 《儿科药学杂志》, vol. 11, no. 03, 31 December 2005 (2005-12-31), pages 27 - 28 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103394072A (en) * 2013-06-26 2013-11-20 千足珍珠集团股份有限公司 Paste for treating nucleus of fresh-water nuclear pearl, and preparation method and application thereof
CN103585334A (en) * 2013-11-17 2014-02-19 戴世玲 Compound diaper ointment
CN103585334B (en) * 2013-11-17 2015-12-09 戴世玲 Compound diaper ointment
WO2016008999A1 (en) * 2014-07-16 2016-01-21 Pierre Fabre Medicament Pharmaceutical and/or cosmetic compositions that are decontaminated by high pressure
CN104479455A (en) * 2014-12-18 2015-04-01 陈林 Marking liquid specially used for radiotherapy and marking pen applying marking liquid
CN104479455B (en) * 2014-12-18 2016-11-30 陈林 Radiotherapy special marker liquid and use the marker pen of this marking fluid

Similar Documents

Publication Publication Date Title
CN103417556A (en) Applications of stilbene compounds
CN103040849A (en) Tannic acid preparation for treating burn, bedsore and diaper dermatitis and preparation method thereof
CN103193772A (en) Preparation method and application of substituted aryl propionic berberine ion-pair compound
CN102670720A (en) Stephania hainanensis total alkaloid extract and preparation method thereof
WO2014118040A1 (en) Extract from indigo tinctoria for the topical treatment and prophylaxis of skin disorders
CN102614111B (en) Glucosamine gel and preparation method thereof
CN103446294B (en) Murrayae folium ET Cacumen extract preparation method, Murrayae folium ET Cacumen extract obtained thereby and application thereof
CN104013878A (en) Foot-bathing medicinal vinegar for quickly treating dermatophytosis and preparation method thereof
CN103751316B (en) A kind of there is antifungal activity waistcoat seed extract and all kinds of preparation and application
CN101301267A (en) Bilobalide B injection and preparation thereof
CN104546928B (en) A kind of Chinese medicine composition and preparation method thereof for treating infant diaper rash
CN104606602A (en) Traditional Chinese medicine lotion for treating skin diseases and preparation method of traditional Chinese medicine lotion
CN103007000A (en) New medicine for treating burns and wounds and preparation method thereof
CN102716380B (en) Compound acne-removal cream and production method thereof
CN100486637C (en) Composition of external remedy for treating hemorrhoids, and preparation method
CN107961320B (en) Pharmaceutical composition for treating acute pancreatitis and preparation method thereof
CN102048926B (en) Chinese medicinal pain-relieving spray for externally treating osteoarthrosis
CN102526387B (en) Medicinal composition for treating early-stage diabetic foot and preparation method thereof
CN103656553A (en) Traditional Chinese medicine preparation for treating arthralgia of bones and joints and soft tissue injuries and preparation method thereof
CN102579401A (en) Gromwell pigment micro-capsules and preparation method thereof
CN102357122A (en) Masking type Chailian oral liquid and preparation method thereof
CN100364505C (en) Fengshining drop pill for treating rheumatism and its preparation method
CN105343723A (en) Preparation method of Juyuan cough relieving micro-capsule
CN100453072C (en) Isatis root drops and preparation thereof
CN104606226A (en) Anti-bacterial inflammation-diminishing traditional Chinese medicine suppository as well as preparation method and quality control method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130417